ivst_admin – NovAccess Global

NovAccess Global Announces Initial Fireside Chat with Glioblastoma Patient Advocate

NovAccess Global Appoints Healthcare IP Consultant Dr. Peter Weinstein to Scientific Advisory Board

NovAccess Global Announces Virtual Annual Shareholders’ Meeting

XSNX Shareholder Meeting

NovAccess Global Receives FDA Approval of Orphan Drug Application for TLR-AD1

Orphan Drug Application Filing

NovAccess Global Announces Fireside Chat with Board Member Perspectives

NovAccess Global Announces Fireside Chat Series for the Investment Community

XSNX Fireside Chat

NovAccess Global Announces Effectiveness of Form S1 Registration Statement

NovAccess Global Announces Uplisting to OTCQB

NovAccess Global Announces Filing of Orphan Drug Application for TLR-AD1

Orphan Drug Application Filing

NovAccess Global CEO Dwain Irvin Featured on MoneyTV

Revolutionary advances in the understanding of how our bodies can fight cancer, and how to put that information to use in treating existing tumors. NovAccess Global’s team of experts is working to strengthen the capability of the human body’s defense against cancer.

Forward-Looking Statements

Contact Us

JOIN US

Stay up-to-date with our journey

Privacy Policy

Forward-Looking Statements